Furthermore, we observed that the methylation of PF4 and TREML2 were high-risk factors with HR > 1 (Figure 2J), whereas methylation in 19 genes was found to be significantly associated with improved survival of AML patients (p < 0.05 and HR < 1) (Figure 2J). This evidence concerns the gene PF4 and acute myeloid leukemia.